ARDX

Ardelyx (ARDX)

Ardelyx Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/09/26	18 : 45	PR Newswire (US)	Investors in Ardelyx, Inc. Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDX	NASDAQ:ARDX	Ardelyx Inc
2024/09/23	18 : 45	PR Newswire (US)	ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:ARDX	Ardelyx Inc
2024/09/19	18 : 45	PR Newswire (US)	The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ARDX	NASDAQ:ARDX	Ardelyx Inc
2024/09/17	07 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/09/16	18 : 45	PR Newswire (US)	Shareholders that lost money on Ardelyx, Inc.(ARDX) should contact The Gross Law Firm about pending Class Action - ARDX	NASDAQ:ARDX	Ardelyx Inc
2024/09/12	18 : 45	PR Newswire (US)	Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDX	NASDAQ:ARDX	Ardelyx Inc
2024/09/09	18 : 45	PR Newswire (US)	Class Action Filed Against Ardelyx, Inc. (ARDX) Seeking Recovery for Investors - Contact The Gross Law Firm	NASDAQ:ARDX	Ardelyx Inc
2024/09/05	21 : 00	GlobeNewswire Inc.	Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference	NASDAQ:ARDX	Ardelyx Inc
2024/09/05	18 : 45	PR Newswire (US)	ARDX LAWSUIT ALERT: The Gross Law Firm Notifies Ardelyx, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline	NASDAQ:ARDX	Ardelyx Inc
2024/08/29	18 : 45	PR Newswire (US)	Ardelyx, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 15, 2024 to Discuss Your Rights - ARDX	NASDAQ:ARDX	Ardelyx Inc
2024/08/27	05 : 49	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/26	18 : 45	PR Newswire (US)	Class Action Filed Against Ardelyx, Inc. (ARDX) - October 15, 2024 Deadline to Join - Contact The Gross Law Firm	NASDAQ:ARDX	Ardelyx Inc
2024/08/23	07 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/23	07 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/23	07 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/23	07 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/23	07 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/22	18 : 45	PR Newswire (US)	Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	NASDAQ:ARDX	Ardelyx Inc
2024/08/22	18 : 45	PR Newswire (US)	Shareholders that lost money on Ardelyx, Inc.(ARDX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More	NASDAQ:ARDX	Ardelyx Inc
2024/08/21	07 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/17	07 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/17	07 : 08	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/17	05 : 28	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ARDX	Ardelyx Inc
2024/08/13	05 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
2024/08/08	21 : 00	GlobeNewswire Inc.	Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer	NASDAQ:ARDX	Ardelyx Inc
2024/08/02	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARDX	Ardelyx Inc
2024/08/02	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARDX	Ardelyx Inc
2024/08/02	05 : 01	GlobeNewswire Inc.	Ardelyx Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:ARDX	Ardelyx Inc
2024/07/31	21 : 02	GlobeNewswire Inc.	Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion	NASDAQ:ARDX	Ardelyx Inc
2024/07/18	21 : 00	GlobeNewswire Inc.	Ardelyx to Report Second Quarter 2024 Financial Results on August 1, 2024	NASDAQ:ARDX	Ardelyx Inc